DailyMarkets.com - Montpelier Provides Guidance

---

• Montpelier Provides Guidance
• Stronger Earnings, But Still Weak
• Earnings Preview: Biogen
• Earnings Preview: Clorox Company
• Hot Option Plays: Market Drifts Lower – EU In Focus
• Third Time Lucky For Amylin’s Bydureon
• Earnings Preview: Boston Scientific
• Quick Charting The Key Daily Levels On INDU And SP500
• Earnings Preview: Very Busy Week Ahead
• Earnings Preview: Cardinal Health
• Earnings Preview: Very Busy Week Ahead
• Earnings Preview: Very Busy Week Ahead
• Guilfoyle: “If Savings Are Up…spending Will Come”
• Smucker Ups Buyback Authorization
• A.M. Best Affirms Ratings On Allstate
• Earnings Preview: McGraw-Hill
• Euro Retreats As Greece Debt Talks Continue

Montpelier Provides Guidance Posted: 30 Jan 2012 11:55 AM PST Montpelier Re Holdings Ltd. (NYSE:MRH) expects fourth quarter 2011 net operating loss in the band of 25 -35 cents per share. The company also estimates its 2011 year end book value to be in the range of $22.60 -$22.70 per share. Montpelier's fourth quarter loss guidance includes an adverse impact of $40 million arising from floods in Thailand, an adverse impact of $26 million from catastrophe losses and also takes into account favorable prior year loss reserve development of $18 million. The … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards

Stronger Earnings, But Still Weak Posted: 30 Jan 2012 11:35 AM PST Third quarter earnings season was a good one, unfortunately we may not be able to say the same about the fourth quarter.  We got off to a very weak start, and while the last week was better, it just pushed the season from being very poor to mediocre at best.  So far 183, or 36.6% of the S&P 500 firms have reported.  However, assuming that all the remaining firms report exactly in line with expectations, then 50.2% of all earnings are in.  Normally, when all is said and … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards

Earnings Preview: Biogen Posted: 30 Jan 2012 11:35 AM PST Biogen Idec Inc. (NASDAQ:BIIB) is slated to announce its fourth quarter and fiscal 2011 results on January 31. The Zacks Consensus Estimate for the fourth quarter is $1.46, 3.5% above the year-earlier earnings of $1.41. The Zacks Consensus Estimate for full year 2011 is $5.82 per share, in line with the company's expectations of posting earnings in excess of $5.70 per share. Third Quarter Highlights Biogen Idec Inc. reported third-quarter earnings per share of $1.59, well above the Zacks Consensus … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards

Earnings Preview: Clorox Company Posted: 30 Jan 2012 11:20 AM PST Global consumer goods retailer, Clorox Company (NYSE:CLX) is scheduled to release its second-quarter 2012 results on Friday, February 03, 2012. The current Zacks Consensus earnings per share (EPS) estimate for the second quarter is 69 cents, representing an annualized growth of 1.16%. The Zacks Consensus Estimate for full-year 2012 stands at $4.07 per share, reflecting a year-over-year decline of 2.05% and falling within the company's guidance range of $4.00 to $4.10 per share. In the surprises … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards

Hot Option Plays: Market Drifts Lower – EU In Focus Posted: 30 Jan 2012 11:18 AM PST Cusick’s Corner To correct or not correct? – that is the question some traders are asking themselves about what the market may do this new trading week. Large cap indices, S&P/NAZ, have been performing very well this new year while their smaller caps, IWM/RUT, have been lagging but as of late they have been moving to the upside (another positive). The EU is still weighing in on the markets. EU leaders meet this week, leaving the door open for another headline and EU markets are at a level … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards

Third Time Lucky For Amylin’s Bydureon Posted: 30 Jan 2012 11:05 AM PST It proved to be third time lucky for Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) and Alkermes plc (NASDAQ:ALKS) with the companies finally gaining US Food and Drug Administration (FDA) approval for their once-weekly type II diabetes treatment, Bydureon (exenatide extended-release for injectable suspension). Bydureon, a glucagon-like peptide-1 (GLP-1) receptor agonist, gained approval as an adjunct to diet and exercise to improve glycemic control in adults with type II diabetes. This means that Bydureon … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards

Earnings Preview: Boston Scientific Posted: 30 Jan 2012 11:00 AM PST Boston Scientific (NYSE:BSX) is scheduled to release its fourth quarter and fiscal 2011 earnings on Thursday, February 2, 2012, before the market opens. The company is expected to report EPS of 8 cents on revenue of $1.908 billion for the quarter and EPS of 44 cents on revenue of $7.662 billion during the fiscal, according to the Zacks Consensus Estimates. As per the guidance provided with third quarter results, Boston Scientific expects to report adjusted EPS of 8–11 cents on revenue of … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards

Quick Charting The Key Daily Levels On INDU And SP500 Posted: 30 Jan 2012 10:50 AM PST Both the Dow Jones and S&P 500 face price challenges at critical levels currently, particularly that of the rising 20d EMA. Let's take a look at these levels to watch and perhaps develop trades on any breakout from these levels. First, the simple S&P 500 Daily Chart: Removing all other factors, the Daily S&P 500 index faces a key "support test" at the confluence of the rising 20d EMA (1,297) and round-number 1,300 level. If buyers step in here, we would be looking for a rally … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards

Earnings Preview: Very Busy Week Ahead Posted: 30 Jan 2012 10:40 AM PST Earnings Preview 1/27/12 Earnings season will be in full swing this week 468 firms scheduled to report, and 99 of those will be members of the S&P 500.  By the end of the week we should have a very good handle on just how weak or strong this earnings season will be. The firms reporting next week read like a who's who of American Industry.  They include: Aflac (NYSE:AFL), Allstate (NYSE:ALL), Clorox (NYSE:CLX), Dow Chemical (NYSE:DOW), International Paper (NYSE:IP), Eli Lilly (NYSE:LLY), Merck … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards

Earnings Preview: Cardinal Health Posted: 30 Jan 2012 10:40 AM PST Cardinal Health (NYSE:CAH) is slated to report second-quarter fiscal 2012 results on Thursday, February 2. The current Zacks Consensus Estimate for the second quarter is 76 cents, representing an estimated 9.94% year-over-year hike. First Quarter Recap Cardinal posted first quarter adjusted earnings per share from continuing operations of 73 cents, beating the Zacks Consensus Estimate by a penny and exceeding the year-ago earnings of 66 cents per share. Total revenues were $26.8 billion in the … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards

Earnings Preview: Very Busy Week Ahead Posted: 30 Jan 2012 10:30 AM PST Earnings Preview 1/27/12 Earnings season will be in full swing this week 468 firms scheduled to report, and 99 of those will be members of the S&P 500.  By the end of the week we should have a very good handle on just how weak or strong this earnings season will be. The firms reporting next week read like a who's who of American Industry.  They include: Aflac (NYSE:AFL), Allstate (NYSE:ALL), Clorox (NYSE:CLX), Dow Chemical (NYSE:DOW), International Paper (NYSE:IP), Eli Lilly (NYSE:LLY), Merck … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards

Earnings Preview: Very Busy Week Ahead Posted: 30 Jan 2012 10:30 AM PST   AFLAC INC (AFL): Free Stock Analysis Report           To read this article on Zacks.com click … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards

Guilfoyle: “If Savings Are Up…spending Will Come” Posted: 30 Jan 2012 10:30 AM PST 01/30/12 Meridian Equity Partners’ Stephen Guilfoyle discusses today’s US economic data, EU developments and weighs this week’s event … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards

Smucker Ups Buyback Authorization Posted: 30 Jan 2012 10:25 AM PST Ohio-based The J. M. Smucker Company (NYSE:SJM)'s Board has announced an increase in the company's share buyback authorization and has also declared a dividend on its shares. Smucker's board has announced to pay its shareholders a quarterly dividend of 48 cents per share on March 1, 2012, of record at the close of business on February 10, 2012. In addition, Smucker's board has increased the share repurchase authorization of the company by five million shares. Currently, Smucker has … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards

A.M. Best Affirms Ratings On Allstate Posted: 30 Jan 2012 10:10 AM PST Last week, the ratings agency, A.M. Best Co. affirmed the issuer credit ratings (ICR) and debt ratings of Allstate Corporation (NYSE:ALL) and its subsidiaries. Accordingly, the ratings agency affirmed the ICR of "a-" of the holding company. Additionally, A.M. Best affirmed the ICR of "aa-" and financial strength rating (FSR) of "A+" of Allstate's subsidiary – Allstate Insurance Group and all of its units except North Light Specialty Insurance Company and First Colonial Insurance … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards

Earnings Preview: McGraw-Hill Posted: 30 Jan 2012 10:00 AM PST The McGraw-Hill Companies Inc. (NYSE:MHP), a publisher and provider of financial information and media services, is slated to report its fourth-quarter 2011 financial results on January 31, 2012. The current Zacks Consensus Estimate for the quarter is 57 cents per share. Revenue as per the Zacks Consensus Estimate is $1,536 million. Third-Quarter 2011, a Synopsis McGraw-Hill posted soft third-quarter 2011 results. The quarterly earnings of $1.21 a share missed the Zacks Consensus Estimate by a … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards

Euro Retreats As Greece Debt Talks Continue Posted: 30 Jan 2012 05:00 AM PST 01/30/12 The euro has fallen from six-week highs against the dollar as a lack of breakthrough in Greece’s debt swap deal has kept investors away from higher-yielding … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards

You are subscribed to email updates from DailyMarkets.com To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610